LD-2 disclosure · 3rd Quarter - Report
GVB BIOPHARMA
Income$50Kfee reported
Client
- Name
- GVB BIOPHARMA
- Description
- CBD extraction and distillation
- Location
- Nevada · United States of America
Registrant
- Description
- Government relations and business consulting
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issueAgriculture
Discussions relating to regulation of the CBD industry Discussions relating to Farm Bill Reauthorization Discussions relating to regulation of Delta-8 THC Monitored H.R. 2891, the SAFE Banking Act of 2023 Monitored S. 1323, the SAFE Banking Act of 2023 Monitored S. 2860, the SAFER Banking Act Monitored discussions related to providing banking services to a legitimate cannabis-related business Monitored H.R. 4368, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024 Monitored executive branch nominations to federal agencies and commissions
LobbyistsTREVOR W. KOLEGO · MICHAEL A. GAFFIN · mr JOHN CHRISTIE iii
TargetedHOUSE OF REPRESENTATIVES